Advertisement

728×90

FDA Expands AI Capabilities and Completes Data Platform Consolidation

Medically reviewed by [Reviewer Name, credentials] — Last updated [date]

FDA announced major steps in its bold initiative to modernize the agency. The agency launched Elsa 4.0, a significant upgrade to the agency’s internal AI tool available to all FDA staff, from scientific reviewers to investigators.


Advertisement

300×250

Important: this content is for informational purposes only and is not medical advice, a prescribing instruction, or a recommendation to act. Consult a licensed healthcare professional before taking any medication.


Related News

Advertisement
320×50